Oligogenic segregation analysis of hereditary prostate cancer pedigrees: evidence for multiple loci affecting age at onset
- PMID: 12740911
- DOI: 10.1002/ijc.11128
Oligogenic segregation analysis of hereditary prostate cancer pedigrees: evidence for multiple loci affecting age at onset
Abstract
Previous studies have suggested strong evidence for a hereditary component to prostate cancer (PC) susceptibility. Here, we analyze 3,796 individuals in 263 PC families recruited as part of the ongoing Prostate Cancer Genetic Research Study (PROGRESS). We use Markov chain Monte Carlo (MCMC) oligogenic segregation analysis to estimate the number of quantitative trait loci (QTLs) and their contribution to the variance in age at onset of hereditary PC (HPC). We estimate 2 covariate effects: diagnosis of PC before and after prostate-specific antigen (PSA) test availability, and presence/absence of at least 1 blood relative with primary neuroepithelial brain cancer (BC). We find evidence that 2 to 3 QTLs contribute to the variance in age at onset of HPC. The 2 QTLs with the largest contribution to the total variance are both effectively dominant loci. We find that the covariate for diagnosis before and after PSA test availability is important. Our findings for the number of QTLs contributing to HPC and the variance contribution of these QTLs will be instructive in mapping and identifying these genes.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.Clin Cancer Res. 1999 Jun;5(6):1275-9. Clin Cancer Res. 1999. PMID: 10389909
-
Two pedigrees of hereditary prostate cancer.Int J Clin Oncol. 2002 Jun;7(3):187-91. doi: 10.1007/s101470200027. Int J Clin Oncol. 2002. PMID: 12109521
-
Screening for prostate cancer in Dutch hereditary prostate cancer families.Int J Cancer. 2008 Feb 15;122(4):871-6. doi: 10.1002/ijc.23165. Int J Cancer. 2008. PMID: 17957791
-
[Constitutional risk factors in prostate cancer].Actas Urol Esp. 2011 May;35(5):282-8. doi: 10.1016/j.acuro.2010.12.009. Epub 2011 Mar 24. Actas Urol Esp. 2011. PMID: 21435741 Review. Spanish.
-
[Update on genetic predisposition to prostate cancer].Bull Cancer. 2015 Jan;102(1):53-6. doi: 10.1016/j.bulcan.2014.12.007. Epub 2014 Dec 29. Bull Cancer. 2015. PMID: 25609482 Review. French.
Cited by
-
Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.Hum Genet. 2008 Feb;123(1):65-75. doi: 10.1007/s00439-007-0451-y. Epub 2007 Dec 8. Hum Genet. 2008. PMID: 18066601
-
Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.Pharmgenomics Pers Med. 2014 Aug 5;7:193-201. doi: 10.2147/PGPM.S38117. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25206306 Free PMC article. Review.
-
Prostate cancer risk-associated genetic markers and their potential clinical utility.Asian J Androl. 2013 May;15(3):314-22. doi: 10.1038/aja.2013.42. Epub 2013 Apr 8. Asian J Androl. 2013. PMID: 23564047 Free PMC article.
-
Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect.Hum Genet. 2006 Feb;118(6):716-24. doi: 10.1007/s00439-005-0099-4. Epub 2005 Nov 23. Hum Genet. 2006. PMID: 16328469
-
Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population.J Cancer Res Clin Oncol. 2014 May;140(5):783-8. doi: 10.1007/s00432-014-1635-1. Epub 2014 Mar 14. J Cancer Res Clin Oncol. 2014. PMID: 24627192 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous